The relationship between the gene expression levels of ERCC1, RRM1, and TUBB3 and the sensitivity to first-line chemotherapy after surgery for NSCLC was prospectively investigated to find out whether ERCC1, RRM1, and TUBB3 genes could be used as markers for sensitivity to first-line chemotherapy. The gene discussed is RRM1; the disease is non-small cell lung carcinoma.